{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Odevixibat", "query": { "intervention": "Odevixibat" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 9, "total_pages": 1, "next_page_url": null, "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-06T19:00:01.227Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03566238", "title": "This Study Will Investigate the Efficacy and Safety of A4250 in Children With PFIC Types 1 or 2", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "PFIC1", "PFIC2" ], "interventions": [ { "name": "A4250 (odevixibat)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Albireo", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Months", "maximum_age": "18 Years", "sex": "ALL", "summary": "6 Months to 18 Years" }, "enrollment_count": 62, "start_date": "2018-05-16", "completion_date": "2020-07-28", "has_results": true, "last_update_posted_date": "2025-11-28", "last_synced_at": "2026-09-06T19:00:01.227Z", "location_count": 12, "location_summary": "Los Angeles, California • San Francisco, California • Denver, Colorado + 8 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03566238" }, { "nct_id": "NCT04674761", "title": "Efficacy and Safety of Odevixibat in Patients With Alagille Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Alagille Syndrome" ], "interventions": [ { "name": "Odevixibat", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Albireo", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 52, "start_date": "2021-03-19", "completion_date": "2022-09-09", "has_results": true, "last_update_posted_date": "2023-11-02", "last_synced_at": "2026-09-06T19:00:01.227Z", "location_count": 9, "location_summary": "San Francisco, California • Baltimore, Maryland • Boston, Massachusetts + 5 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Kansas City", "state": "Missouri" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04674761" }, { "nct_id": "NCT06850038", "title": "A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Alagille Syndrome" ], "interventions": [], "intervention_types": [], "sponsor": "Ipsen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 30, "start_date": "2025-04-22", "completion_date": "2030-11-30", "has_results": false, "last_update_posted_date": "2026-08-31", "last_synced_at": "2026-09-06T19:00:01.227Z", "location_count": 10, "location_summary": "Los Angeles, California • San Francisco, California • Kansas City, Missouri + 6 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Kansas City", "state": "Missouri" }, { "city": "St Louis", "state": "Missouri" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06850038" }, { "nct_id": "NCT04483531", "title": "Odevixibat for the Treatment of Progressive Familial Intrahepatic Cholestasis", "overall_status": "NO_LONGER_AVAILABLE", "study_type": "EXPANDED_ACCESS", "phases": [], "conditions": [ "Progressive Familial Intrahepatic Cholestasis" ], "interventions": [ { "name": "Odevixibat", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Albireo", "sponsor_class": "INDUSTRY", "healthy_volunteers": null, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": null, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2026-07-23", "last_synced_at": "2026-09-06T19:00:01.227Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04483531" }, { "nct_id": "NCT05035030", "title": "Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Alagille Syndrome" ], "interventions": [ { "name": "Odevixibat", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Albireo, an Ipsen Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 62, "start_date": "2021-09-03", "completion_date": "2026-12-31", "has_results": false, "last_update_posted_date": "2026-08-31", "last_synced_at": "2026-09-06T19:00:01.227Z", "location_count": 18, "location_summary": "San Diego, California • San Francisco, California • Atlanta, Georgia + 14 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT05035030" }, { "nct_id": "NCT06258902", "title": "Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Pregnancy Related" ], "interventions": [], "intervention_types": [], "sponsor": "Ipsen", "sponsor_class": "INDUSTRY", "healthy_volunteers": null, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "FEMALE", "summary": "Female only" }, "enrollment_count": 20, "start_date": "2023-09-28", "completion_date": "2032-05-31", "has_results": false, "last_update_posted_date": "2026-08-31", "last_synced_at": "2026-09-06T19:00:01.227Z", "location_count": 1, "location_summary": "Wilmington, North Carolina", "locations": [ { "city": "Wilmington", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT06258902" }, { "nct_id": "NCT04336722", "title": "Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Biliary Atresia" ], "interventions": [ { "name": "Odevixibat", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Albireo, an Ipsen Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "111 Days", "sex": "ALL", "summary": "Up to 111 Days" }, "enrollment_count": 254, "start_date": "2020-07-08", "completion_date": "2026-06-22", "has_results": false, "last_update_posted_date": "2026-07-02", "last_synced_at": "2026-09-06T19:00:01.227Z", "location_count": 30, "location_summary": "Los Angeles, California • Palo Alto, California • San Diego, California + 25 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT04336722" }, { "nct_id": "NCT03659916", "title": "Long Term Safety & Efficacy Study Evaluating The Effect of A4250 in Children With PFIC", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Progressive Familial Intrahepatic Cholestasis" ], "interventions": [ { "name": "A4250 (odevixibat)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Albireo, an Ipsen Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "0 Months", "maximum_age": "100 Years", "sex": "ALL", "summary": "0 Months to 100 Years" }, "enrollment_count": 116, "start_date": "2018-09-28", "completion_date": "2025-12-02", "has_results": true, "last_update_posted_date": "2026-09-03", "last_synced_at": "2026-09-06T19:00:01.227Z", "location_count": 11, "location_summary": "Los Angeles, California • Denver, Colorado • Atlanta, Georgia + 7 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03659916" }, { "nct_id": "NCT05426733", "title": "An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat in Children With Biliary Atresia", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Biliary Atresia" ], "interventions": [ { "name": "Odevixibat", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Albireo, an Ipsen Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 180, "start_date": "2022-07-05", "completion_date": "2026-10-28", "has_results": false, "last_update_posted_date": "2026-08-31", "last_synced_at": "2026-09-06T19:00:01.227Z", "location_count": 10, "location_summary": "Aurora, Colorado • Atlanta, Georgia • Indianapolis, Indiana + 6 more", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Kansas City", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT05426733" } ] }